NCT02878317View on ClinicalTrials.gov

Skin Autofluorescence as a Risk Marker in People Receiving Dialysis.

CompletedOBSERVATIONAL
Enrollment

81

Participants

Timeline

Start Date

September 21, 2016

Primary Completion Date

March 31, 2022

Study Completion Date

March 31, 2022

Conditions
Chronic Kidney Disease
Trial Locations (1)

DE22 3NE

Derby Hospitals NHS Foundation Trust, Derby

All Listed Sponsors
collaborator

University Hospitals of Derby and Burton NHS Foundation Trust

OTHER

lead

University of Nottingham

OTHER

NCT02878317 - Skin Autofluorescence as a Risk Marker in People Receiving Dialysis. | Biotech Hunter | Biotech Hunter